Dr. Reehan Shahzad, MD

Dr. Shahzad practices at Morristown Medical Center in Morristown, New Jersey, part of Atlantic Health System.

Dr. Shahzad's NPI, 1023301215, was assigned on May 19, 2011. Dr. Shahzad graduated from St. George's University School of Medicine in 2010. Dr. Shahzad's Texas license number on file is Q1495.

Dr. Shahzad's primary practice is Morristown Medical Center, at 100 Madison Ave, Morristown, NJ 07962 in Morris County. The practice phone is (973) 971-5450.

Dr. Shahzad's primary practice is Morristown Medical Center in Morristown, New Jersey, part of Atlantic Health System. Dr. Shahzad is also affiliated with HCA Houston Healthcare Tomball. The medical group on file is Acclaimed Heart and Vascular Center. Dmand AI also links Dr. Shahzad to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shahzad practices, 3 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Shahzad's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Shahzad is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Shahzad's licenses on file in 5 states: Texas, New Jersey, Louisiana, South Carolina and New York.

Dmand AI lists aneurysm, angioplasty, atrial fibrillation and flutter, cardiac catheterization, cardiomyopathy, cerebrovascular disease, chronic embolism thrombosis and chronic hypertension among the conditions Dr. Shahzad treats.

CMS data shows 2,900 Medicare services from Dr. Shahzad across 24 procedure codes in 2024, for 472 Medicare patients. Medicare paid $275,023 for them.

CMS counts 472 Medicare patients who saw Dr. Shahzad in 2024. The largest group is 65 to 74, with 193 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.86, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Shahzad's median patient age at 74, with 44% women.

In 2024, Dr. Shahzad wrote 2,526 Medicare Part D claims for 436 patients. 82% of them were for generic drugs. CMS names the drug for 2,325 of them, across 41 drugs with 11 or more claims each, at $523,795 in total drug cost. In 2023, CMS named 1,727 claims across 38 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Shahzad for performance year 2024, reported individually. Dr. Shahzad accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Dr. Shahzad. Dr. Shahzad's most frequent co-author is Mathew Shane Maurer, MD.

CMS Open Payments shows 284 general payments to Dr. Shahzad from 37 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 38% of the total. Boston Scientific Corporation paid the most, $15,906.

Dr. Shahzad graduated from St. George's University School of Medicine in 2010.

Dr. Shahzad is in network with 20 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.